Vancomycin Dosing Calculator

Q: What is vancomycin and when is it used in clinical practice?

Vancomycin is a glycopeptide antibiotic that works by inhibiting bacterial cell wall synthesis. It is primarily used to treat serious infections caused by Gram-positive bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA) and other resistant organisms. Common indications include bloodstream infections (bacteremia), endocarditis, osteomyelitis, pneumonia, meningitis, and compli

Q: What is AUC-guided vancomycin dosing and why has it replaced trough-only monitoring?

AUC-guided vancomycin dosing represents a paradigm shift in therapeutic drug monitoring endorsed by the 2020 ASHP/IDSA/SIDP vancomycin consensus guidelines. The AUC (area under the concentration-time curve) over 24 hours divided by the minimum inhibitory concentration (AUC/MIC) is the pharmacodynamic target that best predicts vancomycin efficacy and toxicity. The recommended target is AUC/MIC of 4

Q: How does kidney function affect vancomycin dosing and what adjustments are needed?

Vancomycin is approximately 90 percent eliminated by the kidneys through glomerular filtration, making renal function the most critical determinant of dosing. Patients with normal kidney function (CrCl greater than 90 mL/min) typically receive vancomycin every 8 to 12 hours. Mild-to-moderate impairment (CrCl 50-89) may require every 12 hours. Moderate-to-severe impairment (CrCl 20-49) typically re

Q: What is a vancomycin loading dose and when should it be given?

A vancomycin loading dose is an initial larger dose (typically 25 to 30 mg/kg of actual body weight, maximum approximately 3000 mg) administered to rapidly achieve therapeutic drug levels. Loading doses are recommended for seriously ill patients where delayed achievement of therapeutic concentrations could lead to treatment failure, including patients with sepsis, meningitis, pneumonia, and endoca

Q: How should vancomycin be dosed in obese patients?

Vancomycin dosing in obese patients requires special consideration because the drug distributes into total body water and adipose tissue increases the volume of distribution. Current guidelines recommend using actual body weight for loading doses (25-30 mg/kg) with a maximum single dose of approximately 3000 mg. For maintenance dosing, clinical practice varies between using actual body weight and

Q: What is red man syndrome and how is it prevented during vancomycin administration?

Red man syndrome (also called vancomycin infusion reaction or vancomycin flushing syndrome) is a histamine-mediated reaction characterized by flushing, erythema, and pruritus of the upper body, neck, and face. It can also cause hypotension and rarely angioedema. It is NOT a true allergic reaction and does not preclude future vancomycin use. Red man syndrome is primarily caused by rapid infusion ra

Calculate initial vancomycin doses based on weight, renal function, and target trough. Enter values for instant results with step-by-step formulas.

Share this calculator

X Facebook LinkedIn

Formula

CrCl = [(140-Age) x Wt x (0.85 if F)] / (72 x SCr); Dose = 15-20 mg/kg; Interval based on CrCl

Initial vancomycin dosing uses Cockcroft-Gault estimated creatinine clearance to determine dosing interval. Loading dose is 25-30 mg/kg actual body weight. Maintenance dose is 15-20 mg/kg using actual or adjusted body weight. Interval: q8h (CrCl>90), q12h (CrCl 50-89), q24h (CrCl 20-49), q48h+ (CrCl<20).

Worked Examples

Example 1: Standard Dosing for MRSA Bacteremia

Problem: A 60-year-old male (80 kg, 178 cm, SCr 1.1 mg/dL) has MRSA bacteremia requiring serious infection dosing. Calculate initial vancomycin regimen.

Solution: IBW = 50 + 2.3 x (70.1 - 60) = 73.2 kg (not obese, use actual weight)\nCrCl = [(140 - 60) x 80 x 1.0] / (72 x 1.1) = 80.8 mL/min\nLoading dose: 25 mg/kg x 80 = 2000 mg\nMaintenance: 20 mg/kg x 80 = 1600 mg, round to 1500 mg\nInterval: CrCl 50-89 = q12h\nDaily dose: 1500 x 2 = 3000 mg/day\nHalf-life: 0.693 / (0.00083 x 80.8 + 0.0044) = 9.1 hours

Result: Vancomycin: Load 2000 mg, then 1500 mg q12h | CrCl: 80.8 mL/min | Obtain trough before 4th dose

Example 2: Renal Impairment Dosing

Problem: A 72-year-old female (65 kg, 160 cm, SCr 2.0 mg/dL) with cellulitis. Calculate adjusted vancomycin dosing.

Solution: IBW = 45.5 + 2.3 x (63.0 - 60) = 52.4 kg (not obese)\nCrCl = [(140 - 72) x 65 x 0.85] / (72 x 2.0) = 26.1 mL/min\nLoading dose: 25 mg/kg x 65 = 1625 mg, round to 1500 mg\nMaintenance: 15 mg/kg x 65 = 975 mg, round to 1000 mg\nInterval: CrCl 20-49 = q24h\nHalf-life: 0.693 / (0.00083 x 26.1 + 0.0044) = 24.8 hours\nSteady state reached after ~5 days

Result: Vancomycin: Load 1500 mg, then 1000 mg q24h | CrCl: 26.1 mL/min | Monitor closely for nephrotoxicity

Frequently Asked Questions

What is vancomycin and when is it used in clinical practice?

Vancomycin is a glycopeptide antibiotic that works by inhibiting bacterial cell wall synthesis. It is primarily used to treat serious infections caused by Gram-positive bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA) and other resistant organisms. Common indications include bloodstream infections (bacteremia), endocarditis, osteomyelitis, pneumonia, meningitis, and complicated skin and soft tissue infections. Vancomycin is administered intravenously for systemic infections and orally for Clostridioides difficile colitis (where it acts locally in the gastrointestinal tract). Accurate dosing is critical because vancomycin has a narrow therapeutic index, with potential for nephrotoxicity at high levels and treatment failure at subtherapeutic levels.

What is AUC-guided vancomycin dosing and why has it replaced trough-only monitoring?

AUC-guided vancomycin dosing represents a paradigm shift in therapeutic drug monitoring endorsed by the 2020 ASHP/IDSA/SIDP vancomycin consensus guidelines. The AUC (area under the concentration-time curve) over 24 hours divided by the minimum inhibitory concentration (AUC/MIC) is the pharmacodynamic target that best predicts vancomycin efficacy and toxicity. The recommended target is AUC/MIC of 400 to 600 mg*h/L (assuming MIC of 1 mg/L). This replaces the previous practice of targeting trough concentrations of 15 to 20 mcg/mL, which was associated with higher nephrotoxicity rates. AUC-guided dosing has been shown to reduce nephrotoxicity by approximately 50 percent while maintaining equivalent efficacy.

How does kidney function affect vancomycin dosing and what adjustments are needed?

Vancomycin is approximately 90 percent eliminated by the kidneys through glomerular filtration, making renal function the most critical determinant of dosing. Patients with normal kidney function (CrCl greater than 90 mL/min) typically receive vancomycin every 8 to 12 hours. Mild-to-moderate impairment (CrCl 50-89) may require every 12 hours. Moderate-to-severe impairment (CrCl 20-49) typically requires every 24 hours. Severe impairment (CrCl below 20) requires every 48 to 72 hours or level-guided dosing. In patients receiving hemodialysis, vancomycin has a prolonged half-life and doses are typically given after each dialysis session based on pre-dialysis levels. Continuous renal replacement therapy requires specialized dosing approaches.

What is a vancomycin loading dose and when should it be given?

A vancomycin loading dose is an initial larger dose (typically 25 to 30 mg/kg of actual body weight, maximum approximately 3000 mg) administered to rapidly achieve therapeutic drug levels. Loading doses are recommended for seriously ill patients where delayed achievement of therapeutic concentrations could lead to treatment failure, including patients with sepsis, meningitis, pneumonia, and endocarditis. The loading dose is based on actual body weight regardless of obesity status and should be infused over 1 to 2 hours (longer for doses greater than 2000 mg) to minimize red man syndrome. The loading dose is independent of renal function because it targets initial distribution volume rather than steady-state kinetics. Not all patients require a loading dose for less severe infections.

How should vancomycin be dosed in obese patients?

Vancomycin dosing in obese patients requires special consideration because the drug distributes into total body water and adipose tissue increases the volume of distribution. Current guidelines recommend using actual body weight for loading doses (25-30 mg/kg) with a maximum single dose of approximately 3000 mg. For maintenance dosing, clinical practice varies between using actual body weight and adjusted body weight. Many institutions use adjusted body weight (IBW + 0.4 times the difference between actual and ideal weight) for maintenance calculations to avoid potential overexposure. Obese patients often have augmented renal clearance, which may necessitate more frequent dosing. Therapeutic drug monitoring is particularly important in this population due to the altered pharmacokinetics.

What is red man syndrome and how is it prevented during vancomycin administration?

Red man syndrome (also called vancomycin infusion reaction or vancomycin flushing syndrome) is a histamine-mediated reaction characterized by flushing, erythema, and pruritus of the upper body, neck, and face. It can also cause hypotension and rarely angioedema. It is NOT a true allergic reaction and does not preclude future vancomycin use. Red man syndrome is primarily caused by rapid infusion rates and is prevented by infusing vancomycin at a rate no faster than 1 gram per hour (or 10 mg per minute). For large doses exceeding 2000 mg, extending the infusion to 2 hours or longer is recommended. Premedication with diphenhydramine (25-50 mg IV) can be administered 30 minutes before infusion for patients with a history of red man syndrome.